{
    "clinical_study": {
        "@rank": "28572", 
        "arm_group": {
            "arm_group_label": "SmartLipo Triplex laser system along with the SideLaze800 hand", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study to evaluate the SmartLipo Triplex laser system along with the\n      SideLaze800 hand piece in the treatment of Acne Scars."
        }, 
        "brief_title": "The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acne Scars", 
        "condition_browse": {
            "mesh_term": [
                "Acne Vulgaris", 
                "Cicatrix"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A healthy male or female between 18 and 65 years old\n\n          -  Has unwanted facial acne scars and wishes to undergo laser treatments.\n\n          -  Is willing to consent to participate in the study.\n\n          -  Is willing to comply with all requirements of the study including being photographed,\n             following post treatment care and attending follow up visits.\n\n        Exclusion Criteria:\n\n          -  The subject is female and pregnant, has been pregnant within the last 3 months, is\n             currently breast feeding or planning a pregnancy during the study period.\n\n          -  The subject is hypersensitive to light exposure OR takes photo sensitized medication.\n\n          -  The subject has active or localized systemic infections.\n\n          -  The subject has a coagulation disorder or is currently using anti-coagulation\n             medication (including but not limited to the heavy use of aspirin) {greater than 81\n             mg per day}).\n\n          -  The subject is currently enrolled in an investigational drug or device trial, or has\n             received an investigational drug or been treated with an investigational device\n             within the planned treatment area 3 months prior to entering this study.\n\n          -  The subject has used Accutane within 6 months prior to enrollment.\n\n          -  The subject has the need to be exposed to artificial tanning devices or excessive\n             sunlight during the trial.\n\n          -  The subject has had prior treatment with parenteral gold therapy (gold sodium\n             thiomalate).\n\n          -  The subject has a history of keloids.\n\n          -  The subject has evidence of compromised wound healing.\n\n          -  The subject has a history of squamous cell carcinoma or melanoma.\n\n          -  The subject has a history of immunosuppression/immune deficiency disorders (including\n             HIV infection or AIDS) or use of immunosuppressive medications.\n\n          -  The subject has an allergy to lidocaine and epinephrine.\n\n          -  The subject has any condition which, in the investigator's opinion, would make it\n             unsafe for the subject to participate in this research study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103816", 
            "org_study_id": "CYN13-PRECIS-ACNE-BD"
        }, 
        "intervention": {
            "arm_group_label": "SmartLipo Triplex laser system along with the SideLaze800 hand", 
            "intervention_name": "SmartLipo Triplex laser system along with the SideLaze800 hand piece", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 1, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Montclair", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "07042"
                }, 
                "name": "New Jersey Plastic Surgery"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars", 
        "overall_official": {
            "affiliation": "Cynosure, Inc.", 
            "last_name": "Patricia Krantz", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To assess level of improvement using the Global Acne Scarring Scale through photographic evaluation.", 
            "safety_issue": "No", 
            "time_frame": "up to 9 months post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103816"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Investigator and subject satisfaction questionnaire", 
            "safety_issue": "No", 
            "time_frame": "up to 9 months post treatment"
        }, 
        "source": "Cynosure, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cynosure, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}